Literature DB >> 28798092

The shorter multidrug-resistant tuberculosis treatment regimen in Singapore: are patients from South-East Asia eligible?

Cynthia B E Chee1,2, Kyi-Win KhinMar2, Li-H Sng3, Roland Jureen4, Jeffery Cutter5, Vernon J M Lee5, Yee-Tang Wang6,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28798092     DOI： 10.1183/13993003.00753-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  13 in total

1.  Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis.

Authors:  Armand Van Deun; Aung Kya Jai Maug; Md Abdul Hamid Salim; Pankaj Kumar Das; Mihir Ranjan Sarker; Paul Daru; Hans L Rieder
Journal:  Am J Respir Crit Care Med       Date:  2010-05-04       Impact factor: 21.405

2.  Resistance profile of drugs composing the "shorter" regimen for multidrug-resistant tuberculosis in Brazil, 2000-2015.

Authors:  Margareth Dalcolmo; Regina Gayoso; Giovanni Sotgiu; Lia D'Ambrosio; Jorge Luiz Rocha; Liamar Borga; Fatima Fandinho; Jose Ueleres Braga; Denise Arakaki Sanchez; Fernanda Dockhorn; Rosella Centis; Giovanni Battista Migliori
Journal:  Eur Respir J       Date:  2017-04-12       Impact factor: 16.671

3.  Eligibility for the Shorter Multidrug-Resistant Tuberculosis Regimen: Ambiguities in the World Health Organization Recommendations.

Authors:  Francis Varaine; Lorenzo Guglielmetti; Helena Huerga; Maryline Bonnet; Nana Kiria; Joseph K Sitienei; Michael Rich; Carole D Mitnick
Journal:  Am J Respir Crit Care Med       Date:  2016-10-15       Impact factor: 21.405

4.  Multidrug-resistant TB in Eastern region of the EU: is the shorter regimen an exception or a rule?

Authors:  Yanina Balabanova; Lena Fiebig; Olga Ignatyeva; Vija Riekstina; Manfred Danilovits; Kaadri Jaama; Edita Davidaviciene; Birute Radiulyte; Christina Marcela Popa; Vladyslav Nikolayevskyy; Francis Drobniewski
Journal:  Thorax       Date:  2017-02-16       Impact factor: 9.139

5.  Applicability of the World Health Organization recommended new shorter regimen in a multidrug-resistant tuberculosis high burden country.

Authors:  Arshad Javaid; Nafees Ahmad; Amer Hayat Khan; Zubair Shaheen
Journal:  Eur Respir J       Date:  2017-01-03       Impact factor: 16.671

6.  Faster for less: the new "shorter" regimen for multidrug-resistant tuberculosis.

Authors:  Giovanni Sotgiu; Simon Tiberi; Lia D'Ambrosio; Rosella Centis; Jan Willem Alffenaar; Jose A Caminero; Marcos Abdo Arbex; Valentina Alarcon Guizado; Alena Aleksa; Simone Dore; Mina Gaga; Gina Gualano; Heinke Kunst; Marie-Christine Payen; Aurora Jazmín Roby Arias; Alena Skrahina; Ivan Solovic; Giorgia Sulis; Marina Tadolini; Alimuddin Zumla; Giovanni Battista Migliori
Journal:  Eur Respir J       Date:  2016-09-01       Impact factor: 16.671

7.  Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe.

Authors:  Christoph Lange; Raquel Duarte; Mathilde Fréchet-Jachym; Gunar Guenther; Lorenzo Guglielmetti; Ioana D Olaru; Olena Oliveira; Rudolf Rumetshofer; Nicolas Veziris; Frank van Leth
Journal:  Am J Respir Crit Care Med       Date:  2016-10-15       Impact factor: 21.405

8.  High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses.

Authors:  A Piubello; S Hassane Harouna; M B Souleymane; I Boukary; S Morou; M Daouda; Y Hanki; A Van Deun
Journal:  Int J Tuberc Lung Dis       Date:  2014-10       Impact factor: 2.373

9.  Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project.

Authors:  Matteo Zignol; Anna S Dean; Natavan Alikhanova; Sönke Andres; Andrea Maurizio Cabibbe; Daniela Maria Cirillo; Andrei Dadu; Andries Dreyer; Michèle Driesen; Christopher Gilpin; Rumina Hasan; Zahra Hasan; Sven Hoffner; Ashaque Husain; Alamdar Hussain; Nazir Ismail; Mostofa Kamal; Mikael Mansjö; Lindiwe Mvusi; Stefan Niemann; Shaheed V Omar; Ejaz Qadeer; Leen Rigouts; Sabine Ruesch-Gerdes; Marco Schito; Mehriban Seyfaddinova; Alena Skrahina; Sabira Tahseen; William A Wells; Ya Diul Mukadi; Michael Kimerling; Katherine Floyd; Karin Weyer; Mario C Raviglione
Journal:  Lancet Infect Dis       Date:  2016-07-07       Impact factor: 25.071

10.  Eligibility for shorter treatment of multidrug-resistant tuberculosis in the European Union.

Authors:  Marieke J van der Werf; Vahur Hollo; Csaba Ködmön; Masoud Dara; Mike Catchpole
Journal:  Eur Respir J       Date:  2017-03-22       Impact factor: 16.671
View more
  4 in total

1.  Implementation of multidrug-resistant tuberculosis (MDR-TB) treatment in Gabon: lessons learnt from the field.

Authors:  U Ateba-Ngoa; J R Edoa; B R Adegbite; E G Rossatanga; D Madiou; A Mfoumbi; C Mevyann; P Achimi Agbo; J Mahoumbou; S Gould; B Lell; A A Adegnika; C Köhler; P G Kremsner; M Massinga-Loembe; A Alabi; M P Grobusch
Journal:  Infection       Date:  2019-05-09       Impact factor: 3.553

Review 2.  New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis.

Authors:  Denise Rossato Silva; Margareth Dalcolmo; Simon Tiberi; Marcos Abdo Arbex; Marcela Munoz-Torrico; Raquel Duarte; Lia D'Ambrosio; Dina Visca; Adrian Rendon; Mina Gaga; Alimuddin Zumla; Giovanni Battista Migliori
Journal:  J Bras Pneumol       Date:  2018-04       Impact factor: 2.624

3.  Few eligible for the newly recommended short course MDR-TB regimen at a large Mumbai private clinic.

Authors:  Zarir F Udwadia; Jeffrey A Tornheim; Shashank Ganatra; Andrea DeLuca; Camilla S Rodrigues; Amita Gupta
Journal:  BMC Infect Dis       Date:  2019-01-28       Impact factor: 3.090

4.  Assessment of burden of drug-resistant tuberculosis at a tertiary care centre in northern India: a prospective single centre cohort study.

Authors:  Richa Misra; Vasudha Kesarwani; Alok Nath
Journal:  BMJ Open       Date:  2021-04-15       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.